IGF1 and prostate cancer: Based on all these premises and considering that diabetes is characterized by hyperglycemia, hyperlipidemia, hyperinsulinemia, and insulin resistance, we hypothesize that diabetes modulates serum PSA, insulin, IGF-1, testosterone, and lipid profile in men with prostate cancer, leading to both late detection and cancer progression.